Search research articles
Contact Us
Filters
Showing results (221-230 of 283) with videos related to
Page
of 29
Sort By:
The Journal of Dermatology
|
March 25, 2025
Two cases of advanced melanoma with BRAF L597 mutation: Options for systemic treatment
Ryo Amagai, Taku Fujimura, Yumi Kambayashi, et al.
The Journal of Dermatology
|
April 17, 2024
Radiation-induced cutaneous squamous cell carcinoma showing a significant response to pembrolizumab: A case report
Manami Takahashi-Watanabe, Taku Fujimura, Ryo Amagai, et al.
European Journal of Dermatology : EJD
|
August 28, 2024
Steroid-resistant Vogt-Koyanagi-Harada-like uveitis due to BRAF/MEK inhibitor, successfully treated with adalimumab
Manami Takahashi-Watanabe, Taku Fujimura, Ryo Amagai, et al.
Brain Research
|
March 15, 2016
Temporal profile of magnetic resonance angiography and decreased ratio of regulatory T cells after immunological adjuvant administration to mice lacking RNF213, a susceptibility gene for moyamoya disease
Atsushi Kanoke, Miki Fujimura, Kuniyasu Niizuma, et al.
Case Reports in Dermatology
|
February 7, 2012
Successful Treatment of MMP-9-Expressing Angiosarcoma with Low-Dose Docetaxel and Bisphosphonate
Masaya Ishibashi, Taku Fujimura, Akira Hashimoto, et al.
Frontiers in Immunology
|
May 23, 2024
Plasminogen activator inhibitor-1 promotes immune evasion in tumors by facilitating the expression of programmed cell death-ligand 1
Abd Aziz Ibrahim, Taku Fujimura, Tomoko Uno, et al.
Skin Health and Disease
|
June 5, 2023
CD25 expression could be a prognostic marker of bexarotene monotherapy for cutaneous T-cell lymphomas
Jun Yamamoto, Kentaro Ohuchi, Ryo Amagai, et al.
Scientific Reports
|
October 31, 2018
Killer immunoglobulin-like receptor genotype did not correlate with response to anti-PD-1 antibody treatment in a Japanese cohort
Yoshihiro Ishida, Chisa Nakashima, Hiroto Kojima, et al.
Journal of Clinical Medicine
|
September 28, 2024
The Evaluation of Immune Checkpoint Inhibitors and BRAF/MEK Inhibitors in Different Therapy Lines for Metastatic Melanoma: A Retrospective Study
Saki Okuda-Hiwatashi, Ryo Amagai, Taku Fujimura, et al.
The Journal of Dermatology
|
March 25, 2020
Case series of cutaneous T-cell lymphomas treated with bexarotene-based therapy
Taku Fujimura, Yota Sato, Kayo Tanita, et al.
Page
of 29
Search research articles
Search
Showing results (221-230 of 283) with videos related to
Sort By:
Page
of 29
The Journal of Dermatology
|
March 25, 2025
Two cases of advanced melanoma with BRAF L597 mutation: Options for systemic treatment
Ryo Amagai, Taku Fujimura, Yumi Kambayashi, et al.
The Journal of Dermatology
|
April 17, 2024
Radiation-induced cutaneous squamous cell carcinoma showing a significant response to pembrolizumab: A case report
Manami Takahashi-Watanabe, Taku Fujimura, Ryo Amagai, et al.
European Journal of Dermatology : EJD
|
August 28, 2024
Steroid-resistant Vogt-Koyanagi-Harada-like uveitis due to BRAF/MEK inhibitor, successfully treated with adalimumab
Manami Takahashi-Watanabe, Taku Fujimura, Ryo Amagai, et al.
Brain Research
|
March 15, 2016
Temporal profile of magnetic resonance angiography and decreased ratio of regulatory T cells after immunological adjuvant administration to mice lacking RNF213, a susceptibility gene for moyamoya disease
Atsushi Kanoke, Miki Fujimura, Kuniyasu Niizuma, et al.
Case Reports in Dermatology
|
February 7, 2012
Successful Treatment of MMP-9-Expressing Angiosarcoma with Low-Dose Docetaxel and Bisphosphonate
Masaya Ishibashi, Taku Fujimura, Akira Hashimoto, et al.
Frontiers in Immunology
|
May 23, 2024
Plasminogen activator inhibitor-1 promotes immune evasion in tumors by facilitating the expression of programmed cell death-ligand 1
Abd Aziz Ibrahim, Taku Fujimura, Tomoko Uno, et al.
Skin Health and Disease
|
June 5, 2023
CD25 expression could be a prognostic marker of bexarotene monotherapy for cutaneous T-cell lymphomas
Jun Yamamoto, Kentaro Ohuchi, Ryo Amagai, et al.
Scientific Reports
|
October 31, 2018
Killer immunoglobulin-like receptor genotype did not correlate with response to anti-PD-1 antibody treatment in a Japanese cohort
Yoshihiro Ishida, Chisa Nakashima, Hiroto Kojima, et al.
Journal of Clinical Medicine
|
September 28, 2024
The Evaluation of Immune Checkpoint Inhibitors and BRAF/MEK Inhibitors in Different Therapy Lines for Metastatic Melanoma: A Retrospective Study
Saki Okuda-Hiwatashi, Ryo Amagai, Taku Fujimura, et al.
The Journal of Dermatology
|
March 25, 2020
Case series of cutaneous T-cell lymphomas treated with bexarotene-based therapy
Taku Fujimura, Yota Sato, Kayo Tanita, et al.
Page
of 29